Zobrazeno 1 - 10
of 6 717
pro vyhledávání: '"L Jeffrey"'
Autor:
Jie Xu, Swaminathan Iyer, Mahsa Khanlari, Shaoying Li, Roberto N Miranda, Cameron Yin, Pei Lin, Guilin Tang, Sergej N Konoplev, L Jeffrey Medeiros
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/aa4af7e9d3f34045b449e1cf478af334
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0238477 (2020)
Somatic copy number alterations (CNA) are common in endometrial serous carcinoma (ESC). We used the Tumor Cancer Genome Atlas Pan Cancer dataset (TCGA Pan Can) to explore the impact of somatic CNA and gene expression levels (mRNA) of cancer-related g
Externí odkaz:
https://doaj.org/article/fbefc4544e3a4ed5942e499b5e8ab8f1
Publikováno v:
eJHaem, Vol 5, Iss 6, Pp 1265-1268 (2024)
Abstract Chronic lymphocytic leukemia (CLL) is an indolent low‐grade B‐cell neoplasm that generally responds well to treatment. Rarely, CLL cases exhibit an IGH::CCND1 rearrangement, presenting a diagnostic challenge in distinguishing between clo
Externí odkaz:
https://doaj.org/article/82c0ea75858a45b3a9801f39dfe1bef2
Autor:
Santiago Montes-Moreno, Mark J Routbort, Elijah J Lohman, Bedia A Barkoh, Rashmi Kanagal-Shamanna, Carlos E Bueso-Ramos, Rajesh R Singh, L Jeffrey Medeiros, Raja Luthra, Keyur P Patel
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204218 (2018)
ASXL1 (additional sex combs like 1) is a gene that is mutated in a number of hematological neoplasms. The most common genetic alteration is c.1934dupG p.Gly646fs. Previous publications have shown that ASXL1 mutations have a negative prognostic impact
Externí odkaz:
https://doaj.org/article/211084062a8445818fd012187eafcc83
Autor:
Dai Chihara, Michelle A Fanale, Roberto N Miranda, Mansoor Noorani, Jason R Westin, Loretta J Nastoupil, Fredrick B Hagemeister, Luis E Fayad, Jorge E Romaguera, Felipe Samaniego, Francesco Turturro, Hun J Lee, Sattva S Neelapu, M Alma Rodriguez, Michael Wang, Nathan H Fowler, Richard E Davis, L Jeffrey Medeiros, Yasuhiro Oki
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0191461 (2018)
We performed a retrospective analysis to identify risk factors and survival outcome for central nervous system (CNS) relapse of peripheral T-cell lymphoma (PTCL) by histologic type. Records of 600 PTCL patients diagnosed between 1999 and 2014 were an
Externí odkaz:
https://doaj.org/article/73ceca117ba94c9caecbd4ff828737e7
Autor:
Meenakshi Mehrotra, Dzifa Yawa Duose, Rajesh R Singh, Bedia A Barkoh, Jawad Manekia, Michael A Harmon, Keyur P Patel, Mark J Routbort, L Jeffrey Medeiros, Ignacio I Wistuba, Rajyalakshmi Luthra
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0181968 (2017)
Next generation sequencing based tumor tissue genotyping involves complex workflow and a relatively longer turnaround time. Semiconductor based next generation platforms varied from low throughput Ion PGM to high throughput Ion Proton and Ion S5XL se
Externí odkaz:
https://doaj.org/article/bb549dfe68a64ba9828eeddd3a89200d
Autor:
Penny Fang, MD, MBA, Sonal S. Noticewala, MD, Susan Y. Wu, MD, Jillian R. Gunther, MD, PhD, Ethan B. Ludmir, MD, L. Jeffrey Medeiros, MD, Paolo Strati, MD, Ranjit Nair, MD, Chijioke Nze, MD, Loretta J. Nastoupil, MD, Sairah Ahmed, MD, Luis Malpica Castillo, MD, Luis Fayad, MD, Jason Westin, MD, Sattva Neelapu, MD, Christopher Flowers, MD, Auris Huen, MD, Swaminathan P. Iyer, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101650- (2024)
Purpose: Extranodal NK/T-cell lymphoma (ENKTCL) is rare in the Western Hemisphere and is commonly treated with combined modality therapy (CMT). Methods and Materials: We retrospectively reviewed 35 patients treated with Ann Arbor stage I/II ENKTCL be
Externí odkaz:
https://doaj.org/article/1b79041406a44fdbaeef87666f666797
Autor:
Laurie L. Kenney, Rebecca Suet-Yan Chiu, Michelle N. Dutra, Alexandra Wactor, Chris Honan, Lukas Shelerud, Joshua J. Corrigan, Kelly Yu, Joseph D. Ferrari, Kate L. Jeffrey, Eric Huang, Paul L. Stein
Publikováno v:
Cell Reports Medicine, Vol 5, Iss 9, Pp 101717- (2024)
Summary: Indoleamine-2,3-dioxygenase (IDO)1 degrades tryptophan, obtained through dietary intake, into immunoregulatory metabolites of the kynurenine pathway. Deficiency or blockade of IDO1 results in the enhancement of autoimmune severity in rodent
Externí odkaz:
https://doaj.org/article/02d2479310034e2f931923d7ec2377fe